跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ofloxasaph-Ot - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ofloxasaph-Ot
Approved
STANDARD
Ofloxasaph-Ot
Althea Pharma Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
565719df764a5409
Company
Althea Pharma Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
565719df764a5409
Drug Approval Philippines Name
Ofloxasaph-Ot
Product Name
Ofloxasaph-Ot
Registration Number
DRP-13320
Brand Name
Ofloxasaph-Ot
Generic Name
Ofloxacin
Dosage Form
Solution For I.V. Infusion
Dosage Strength
2 mg/mL (200 mg/100 mL)
Manufacturer
Althea Pharma Pvt. Ltd.
Trader
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
26 January 2023
Expiry Date
26 January 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
565719df764a5409
Type
Standard
Back to Philippines FDA Approvals